• CUA - A Phase 2 multicenter prospective open label 2-dose level clinical safety and efficacy evaluation of injection of NX-1207 for the treatment of low risk, localized (T1c) Prostate Cancer.
  • GUH - Phase II Study to Evaluate the Efficacy of Intensity Modulated Radiation Therapy with Hypofractionated Radiosurgical Boosts in the Treatment of Clinically Localized Prostate Cancer
  • GUH - CALGB 70807 The Mens Eating and Living (MEAL) Study. A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
  • GWU - Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients with High Risk localized Prostate Cancer
  • GWU - A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy
  • INOVA - A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
  • INOVA - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
  • JHMI - J1192 A Randomized Controlled Trial of ProstAtak as Adjuvant to Up-Front Radiation Therapy for Localized Prostate Cancer
  • JHMI - J1207 Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol and daily genistein (G-2535) versus placebo in men with early stage prostate cancer undergoing prostatectomy 
  • JHMI - J1265 A Neoadjuvant Immunologic Study of Androgen Deprivation Therapy Combined With a GM-CSF-secreting Allogeneic Prostate Cancer Vaccine and Low-dose Cyclophosphamide in Men With High-risk Localized Prostate Cancer Undergoing Radical Prostatectomy
  • JHMI - J0859 Multiparametric MRI for Assessing Radiotherapy Treatment Response of Prostate Cancer
  • NCI 09-C-0120 An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin
  • NCI 11-C-0098 Evaluation of Ferumoxytol enhanced MRI for the detection of lymph node involvement in CaP
  • NCI 11-C-0158 MR Image Guided Focal Therapy in Prostate Cancer
  • NCI 11-C-0247 A randomized phase II study of L-BLP25 in combination with standard androgen deprivation therapy and radiation therapy for newly diagnosed, high risk prostate cancer patients.
  • NCI 13-C-0119 Evaluation of local response of CaP to irradiation using multiparametric MRI & MR guided biopsies
  • NCI - A Phase II Trial of Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer
  • UMD - Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer
  • UMD - A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
  • UMD - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
  • UMD - A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer
  • UMD - Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer. A Phase III Randomized Trial
  • WHC - CALGB 70807 The Mens Eating and Living (MEAL) Study. A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
  • WRNMMC - A Randomized Controlled Trial of ProstAtak as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
  • WRNMMC - The Men's Eating and Living (MEAL) Study - A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
  • WRNMMC - A Multicenter Clinical Study of the Sonablate 500 (Sonablate) for the Treatment of Locally Recurrent Prostate Cancer With HIFU
  • WRNMMC - Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer